Hem › Cancer (alla typer) › Nebraska › Lincoln
Kliniska studier för Cancer (alla typer) i Lincoln, NE
3 studier för Cancer (alla typer) söker deltagare vid platser i och runt Lincoln (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
RekryterarFas 2/3
- Nho - Revive Research Institute /ID# 277569, Lincoln
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekryterarFas 1
- NHO Revive Research Institute, LLC /ID# 267869, Lincoln
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
RekryterarFas 2/3
- Nho - Revive Research Institute /ID# 276115, Lincoln
Cancer (alla typer)-studier i andra städer
- Houston, TX121 studier
- New York City, NY110 studier
- Boston, MA86 studier
- Los Angeles, CA73 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Durham, NC58 studier
- Washington, DC58 studier
- Chicago, IL51 studier
- Seattle, WA49 studier
- Atlanta, GA49 studier
- Arlington, VA48 studier
Andra studier i Lincoln
- Icke-småcellig lungcancer16 studier
- Hjärtsvikt8 studier
- Lungcancer7 studier
- Kranskärlssjukdom5 studier
- Bröstcancer4 studier
- Övervikt4 studier
- Schizofreni4 studier
- Kolorektal cancer4 studier
- Multipelt myelom3 studier
- Melanom3 studier
- Amyotrofisk lateralskleros3 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.